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Background. The mechanisms of cyclosporine (CsA)-induced
nephrotoxicity are not fully understood. While hemodynamic
changes may be involved in vivo, there is also some evidence for
tubular involvement. We previously showed direct toxicity of CsA
in the LLC-PK1 renal tubular cell line. In the current study we
examined mechanisms (apoptosis or necrosis) of cell death induced
by CsA in the LLC-PK1 renal proximal tubular cell line. The possible
role of the Fas (APO-1/CD95) antigen-Fas ligand system in the
mediation of CsA-induced cell death was also investigated.
Methods. Cells were treated with CsA (0.42 nM to 83 mM) for 24
hours and alterations in DNA and protein synthesis and mem-
brane integrity were examined. Flow cytometry was used to
investigate: (i) alterations in the DNA content and cell cycle; (ii)
the forward (FSC) and side (SSC) light scattering properties
(indicators of cell size and granularity, respectively); (iii) the
externalization of phosphatidylserine (PS) as a marker of early
apoptosis using FITC-annexin V binding; and (iv) expression of
the apoptotic Fas protein. DNA fragmentation in apoptotic cells
was also determined by the TUNEL assay.
Results. CsA (all doses) caused a block in the G0/G1 phase of
the cell cycle as indicated by a decrease in DNA synthesis and
supported by an increase in the % of cells in the G0/G1 phase with
concurrent decreases of those in the S and G2/M phases. The
effect on protein synthesis appeared to be much less. Lower doses
of CsA (4.2 nM) caused the appearance of a “sub-G0/G1” peak,
indicative of reduced DNA content, on the DNA histogram that
was paralleled by a reduction in cell size and an increased cell
granularity and an increase in FITC-annexin V binding. DNA
fragmentation was evident in these cells as assessed using the
TUNEL assay. Higher doses of CsA increased cell size and
decreased cell granularity and reduced membrane integrity. Ex-
pression of Fas, the cell surface molecule that stimulates apopto-
sis, was increased following low dose CsA exposure.
Conclusions. These results indicate that CsA is directly toxic to
LLC-PK1 cells with reduced DNA synthesis and cell cycle block-
ade. The mode of cell death, namely apoptosis or necrosis, is dose
dependent. Fas may be an important mediator of CsA induced
apoptosis in renal proximal tubular cells.
The immunosuppressive agent cyclosporine A (CsA) is
widely used to treat allograft rejection and in the treatment
of various autoimmune disorders [1]. A major limiting
factor in the use of CsA is nephrotoxicity which still
remains a significant problem [2]. CsA nephrotoxicity is
associated with acute changes in renal hemodynamics
followed by irreversible tubular injury [3]. Morphological
evidence suggests that the early sublethal tubular damage is
confined to the S3 segment of the proximal tubule. This
includes swelling of the endoplasmic reticulum and appear-
ance of large vacuoles [4]. Whether these tubular alter-
ations are secondary to hemodynamic changes or reflect
direct tubular toxicity of CsA has not been established.
With in vivo experiments it is difficult to distinguish be-
tween these possibilities. We have previously shown, using
an in vitro model system, that CsA is directly toxic to renal
tubular cells in culture with a relative site selective action to
the proximal tubular region of the nephron [5, 6]. In
addition, low doses of CsA were seen to cause sustained
elevations in intracellular calcium prior to a loss in cellular
viability.
Cellular injury can trigger a variety of responses includ-
ing adaptation, repair, proliferation and cell death in the
form of either apoptosis or necrosis. Apoptosis is a genet-
ically controlled form of cell death distinct to necrosis that
can serve as a molecular selection process for both normal
physiological processes and during toxic damage and dis-
ease states [7, 8]. It is characterized by cell shrinkage,
chromatin condensation and systematic cleavage of DNA
into intranucleosomal length fragments by endonuclease
activity that may be calcium or magnesium dependent [9].
Apoptosis has been implicated as an important pathogenic
mechanism in renal disease [10] and has been shown to
occur both during renal development and following renal
injury such as that observed in acute renal failure and
chronic glomerulonephritis. The renal proximal tubular
epithelial cell has been shown to be a target for apoptotic
cell death following ischemic or toxic injury [11, 12], and
indeed apoptosis has been shown to play a crucial role in
the growth and differentiation of proximal tubular cells in
primary culture [13].
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The Fas (APO-1/CD95) antigen-Fas ligand system me-
diates apoptotic cell death in a number of cell types and Fas
up-regulation has been observed in glomerulonephritis
[14]. Furthermore, agonistic anti-Fas antibodies have been
shown to induce glomerular cell apoptosis in mice in vivo
[15].
It has been postulated that the form of cell death
recruited by the cell following toxic injury is very much dose
dependent [16]. Cell death induced in proximal tubular
epithelial cells by the nephrotoxic agent, cisplatin, was
shown to be concentration dependent, with low concentra-
tions inducing apoptosis and higher concentrations induc-
ing necrosis [17].
We have examined the mechanisms of cell death induced
by CsA in the LLC-PK1 renal proximal tubular cell line.
The studies demonstrated that high concentrations of CsA
(mM range) induce necrosis whereas lower concentrations
(nM range) induce cell death with characteristics typical of
apoptosis. Fas may be an important mediator of CsA
induced apoptosis in renal proximal tubular cells.
METHODS
Materials
Cyclosporine A was a generous gift from Novartis Phar-
maceutical Ltd. The mouse monoclonal Fas antibody was
obtained from Dr. Hugh McGlynn, University of Ulster,
Coleraine, Northern Ireland, who had originally obtained it
as a gift from Itoh and co-workers [18]. The experiments
were also repeated and replicated using a commercially
available rabbit polyclonal Fas antibody (Santa Cruz Bio-
technology). All other reagents were of the highest avail-
able purity from commercial sources.
Cell culture
LLC-PK1 cells were obtained from ATCC (USA). Cells
were maintained in DMEM supplemented with 10% FCS,
2 mM glutamine, incubated at 37°C in 95% O2/5% CO2 and
grown to confluency in 75 cm2 flasks (Costar).
Cell treatment
CsA was prepared as a stock solution (4.2 mM) by
dissolving the powder in 100% ethanol. For DNA and
protein synthesis assays, cells were seeded into 24 well
plates (Greiner) at a density of 2 3 104 cells/ml. Twenty-
four hours later they were treated with CsA (0.42 nM to 83
mM) or with vehicle alone (1:100 ethanol) for 24 hours. For
flow cytometry cells, were cultured in 25 cm2 costar flasks
(1 3 106 cells/flask).
Estimation of DNA and protein synthesis
DNA and protein synthesis were measured by 3H-thymi-
dine and 14C-leucine incorporation, respectively. Cells were
incubated in 1 ml of DMEM containing either 0.25 mCi
3H-thymidine/ml or 0.25 mCi 14C-leucine/ml for four hours
at 37°C. Uptake was terminated by washing 4 times in
ice-cold PBS and the cells were solubilized in 2% (wt/vol)
SDS. The radioactivity was determined by liquid scintilla-
tion counting.
Flow cytometric DNA analysis
Single cell suspensions were prepared by treating the
cells with a trypsin/EDTA mixture in DMEM. Spontane-
ously detached cells present in the culture medium were
also included in the analysis. Cell suspensions (1 3 106)
were pelleted, resuspended in 200 ml of PBS and fixed for
at least 30 minutes at 4°C in 2 ml of 70% ice-cold ethanol.
Cells were washed twice in PBS, resuspended in 800 ml PBS
to which was added 100 ml of 1 mg/ml RNAse A (Sigma)
and 100 ml of 400 mg/ml propidium iodide (PI), and allowed
to incubate for 30 minutes at 37°C. Cells were analyzed on
a FACStar Plus Flow Cytometer (Becton Dickinson, Aalst,
Europe) with laser excitation at 488 nm using a 639 nm
band pass filter to collect the red PI fluorescence. Forward
(FSC) and side (SSC) light scatter were also recorded as
indices of cell size and granularity, respectively. The per-
centages of cells in the various phases of the cell cycle
namely G0/G1, S and G2/M were assessed using the CELL-
FITy program on the flow cytometer.
Determination of cell injury
Cellular viability was measured by assessing trypan blue
exclusion and lactate dehydrogenase (LDH) release as
previously described [16, 19].
TUNEL staining
DNA fragmentation was assessed using an Apoptosis
Detection System, Fluorescein, from Promega Corp.
(USA). In brief, cells were cytospun onto glass slides and
fragmented DNA of apoptotic cells was measured by the
catalytic incorporation of fluorescein-12-dUTP at the
39-OH ends using the enzyme Terminal deoxynucleotidyl
Transferase [20]. The fluorescein-12-dUTP-labeled DNA
was visualized using a fluorescent microscope.
FITC-annexin V binding
FITC-annexin V binding was determined using an apo-
ptosis detection kit (NX50) commercially available from
R&D Systems (Europe). In brief, cells were resuspended in
1 3 binding buffer [21] at a concentration of 1 3 106
cells/ml. One hundred microliters of the cells (1 3 105)
were incubated with FITC-conjugated annexin V (1 mg/ml)
for 15 minutes at room temperature. Labeled cells were
analyzed on a FACStar Plus flow cytometer with laser
excitation at 488 nm using a 530 nm band pass filter to
collect the FITC fluorescence. Membrane integrity was
determined immediately after flow cytometric analysis us-
ing trypan blue exclusion as described above.
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Fas flow cytometric immunofluoresence
Single cells suspensions (1 3 106) were washed in 1 ml of
PBS. They were incubated for 30 minutes on ice with 1:100
monoclonal (mouse) anti-Fas antibody diluted in PBS.
Following three washes in PBS the presence of bound
antibody was detected by incubating with 1:100 goat anti-
mouse FITC conjugated antibody (DAKO, UK) in PBS for
30 minutes on ice. Labeled cells were washed twice in PBS
and analyzed on a FACStar Plus flow cytometer with laser
excitation at 488 nm using a 530 nm band pass filter to
collect the FITC fluorescence. The appropriate controls
were maintained by the omission of the primary antibody or
by its replacement with pre-immune serum.
Western blot analysis of Fas expression
Twenty micrograms of LLC-PK1 whole cell extracts were
resolved on 12% SDS-PAGE. The gel was blotted to
nitrocellulose using a semi-dry transfer system. For the
detection of Fas expression, the blot was then blocked for
one hour at room temperature with PBS containing 5%
(wt/vol) milk fat proteins/PBS. Following three washes in
PBS and in PBS-0.05% (vol/vol) tween-20 (PBS-T) the blot
was incubated for two hours with 1:100 polyclonal (rabbit)
anti-Fas antibody (Santa Cruz Biotechnology) diluted in
3% milk fat proteins/PBS. The blot was washed again and
incubated with a goat anti-rabbit horseradish peroxidase
conjugated secondary antibody (Promega Corp., USA).
The blot was developed using enhanced chemiluminesence
(Boehringer Mannheim).
Data analysis
Results are expressed as the mean 6 SEM from three to
six independent experiments. Data were statistically ana-
lyzed by one-way ANOVA followed by the Dunnett post-
test and P , 0.05 was deemed significant.
RESULTS
DNA and protein synthesis
CsA treatment for 24 hours in LLC-PK1 cells signifi-
cantly decreased DNA synthesis in a dose dependent
manner as assessed using 3H-thymidine incorporation (Fig.
1A). Cells were treated on day 2 of culture in the log phase
of growth and therefore appeared very sensitive to CsA
induced alterations in DNA synthesis. Previous studies
from our laboratory have shown that necrosis, as assessed
using neutral red uptake and MTT conversion, was not
evident in LLC-PK1 cells treated with doses of CsA less
than 0.42 mM [5]. However, in this study, very low doses of
CsA (below 0.42 mM) were observed to significantly inhibit
DNA synthesis, indicating that DNA damage is a very
sensitive indicator of CsA induced nephrotoxicity.
CsA also caused dose dependent decreases in protein
synthesis as measured using 14C-leucine incorporation (Fig.
1B). However, much higher doses of CsA (21 mM or
greater) were required to inhibit protein synthesis than
were required to effect DNA synthesis, suggesting that
protein synthesis is less sensitive to CsA induced damage.
Flow cytometric cell cycle analysis
Flow cytometric analysis of the cell cycle of LLC-PK1
cells provided compatible evidence for the decrease in
DNA synthesis observed by 3H-thymidine incorporation.
CsA treatment for 24 hours caused dose dependent in-
creases in the percentage of cells in the G0/G1 (resting)
phase that was paralleled by decreases in the percentages of
cells in the S (DNA synthesis) and G2/M (mitotic/dividing)
phases (Table 1). For example, at 4.2 nM CsA, the following
Fig. 1. Effect of cyclosporine (CsA) on DNA and protein synthesis in
LLC-PK1 cells. (A)
3H-thymidine incorporation was used as an index of
DNA synthesis. (B) 14C-leucine incorporation was used as an index of
protein synthesis. In both cases results are expressed as the DPM of
radioisotope incorporated per well and represent the mean 6 SEM of 3
independent experiments each performed in quadruplicate. *P , 0.05,
**P , 0.01.
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changes from control were detected: G0/G1 phase, 47 6 4
to 64 6 4; S phase, 28 6 3 to 18 6 4; and G2/M, 28 6 5 to
18 6 1 (Table 1). It can be seen that very low doses of CsA
(including 0.42 nM) were capable of mediating the cell cycle
changes seen, providing further evidence for the impor-
tance of DNA damage in CsA induced toxicity.
Cellular injury assays
The cellular injury induced by representative high (42
mM) and low (4.2 nM) doses of CsA was also assessed by
investigating trypan blue exclusion and LDH release (Fig.
2). A dose of 42 mM CsA caused a 20% decrease in
membrane integrity with only 80.1 6 3.3% of cells exclud-
ing trypan blue after CsA (42 mM) exposure (N 5 6, P ,
0.01, Fig. 2A). No significant alteration in membrane
integrity was observed in cells treated with 4.2 nM CsA, as
indicated by the finding that 97.5 6 0.6% (N 5 6) of cells
excluded trypan blue. Furthermore, 42 mM CsA caused a
significant increase in LDH release (1.4 6 0.03-fold over
basal, P , 0.01, Fig. 2B) whereas 4.2 nM CsA caused no
significant increase in LDH release in LLC-PK1 cells.
Flow cytometric assessment of apoptosis using DNA
analysis and light scatter measurements
Figure 3 panels A, B and C depicts flow cytometric DNA
histograms where the amount of fluorescence emitted is
directly proportional to the amount of DNA present in the
cells. In all cases cellular debris was gated out on the basis
of cell scatter prior to analysis. CsA treatment for 24 hours
with a low dose (4.2 nM) was seen to cause the appearance
of a “sub-G0/G1” peak on the DNA histogram (Fig. 3B),
which was absent in both the control cells (Fig. 3A) and the
cells treated with 4.2 mM CsA (Fig. 3C). This “sub-G0/G1”
peak represents a population of cells with reduced DNA
stainability that is most likely due to DNA fragmentation.
The gates for the “sub-G0/G1 peak” were established by
using cells that were treated with cisplatin, a known inducer
of apoptosis in renal cells [17]. Cisplatin (50 mM) was
observed to cause the appearance of a “sub-G0/G1” peak
that represented 40% of the total cell population (results
not shown).
Fig. 2. Effect of cyclosporine (CsA) on trypan blue exclusion and LDH
release in LLC-PK1 cells. LLC-PK1 cells were exposed to 4.2 nM and 42
mM CsA for 24 hours. (A) For trypan blue exclusion (% membrane
integrity) cells were trysinized, mixed with trypan blue and viewed under
a light microscope. Cells that were blue were scored as having an altered
membrane integrity. (B) Fractional release of LDH was determined by the
equation S/(S 1 C); where S 5 LDH in the supernatant and C 5 LDH in
the monolayer, after cell lysis. Results represent the mean 6 SEM of 3 to
6 independent experiments. **P , 0.01.
Table 1. Dose-response effects of cyclosporine (CsA) on the cell cycle
and apoptosis in LLC-PK1 cells
Treatment
% Cells in each phase
of the cell cycle
excluding apoptotic cells
Cyclosporine A % G0/G1 % S % G2/M % Apoptosis
Control 47 6 4 28 6 3 28 6 5 3 6 1
0.42 nM 65 6 9a 22 6 4 13 6 5 N/D
4.2 nM 64 6 4a 18 6 4 18 6 1 21 6 5b
42 nM 67 6 6a 16 6 2a 17 6 4 14 6 1b
420 nM 64 6 4a 16 6 1a 20 6 3 12 6 2b
4.2 mM 77 6 3b 12 6 3b 11 6 1b 8 6 1b
21 mM 85 6 1b 5 6 1b 10 6 1b 6 6 1
Abbreviations are in the Appendix. LLC-PK1 cells were treated on day
2 of culture with 0.42 nM to 21 mM CsA for 24 hr. The percentage of cells
in each phase of the cell cycle excluding apoptotic cells was analysed using
the CELLFIT™ program on a BD FACStar Plus Flow Cytometer. Results
are expressed as the percentage of cells in the appropriate phase (% of
10,000 events) and represent the mean 6 SEM of 3 to 6 independent
experiments. The percentage of apoptotic cells was quantified as the
percentage of total cells displaying reduced DNA stainability in the
sub-G0/G1 peak.
a P , 0.05, b P , 0.01
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Fig. 3. Flow cytometric analysis of the effect of cyclosporine (CsA) treatment for 24 hours on the DNA profile, size and granularity of LLC-PK1 cells.
Results from one representative experiment that represents 10,000 events (cells) are shown. (A) DNA profile of control cells. (B) DNA profile of 4.2
nM CsA treated cells. (C) DNA profile of 4.2 mM CsA treated cells. (D) Light scattering properties of control cells; FSC, size and SSC, granularity. (E)
Light scattering properties of 4.2 nM CsA treated cells. (F) Light scattering properties of 4.2 mM CsA.
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On examination of the light scattering properties of the
control cells (Fig. 3D) one main population could be
observed that appeared to have a normal distribution.
However, analysis of the cells treated with 4.2 nM CsA (Fig.
3E) revealed two cell populations: one major population
and also a subpopulation. The major population had simi-
lar characteristics to that of the control cells. The subpopu-
lation displayed a decrease in forward light scatter (FSC)
and an increase in side scatter (SSC) indicative of cell
shrinkage and increased granularity, respectively, both in-
dices representing characteristics of apoptotic cell death.
The DNA fluorescence of this subpopulation when gated
appeared to be equal to that of the “sub-G0/G1” peak seen
in Figure 3B. This subpopulation was not apparent in the
cells treated with 4.2 mM CsA (Fig. 3F).
Time dependent induction of apoptosis by 4.2 nM CsA
Table 2 shows a time course for the induction of apopto-
sis as assessed by DNA analysis and appearance of the
“sub-G0/G1” peak in LLC-PK1 cells. It can be seen that
CsA induced apoptosis in a time dependent manner, with
the maximum apoptosis occurring at 24 hours post-treat-
ment (14 6 3% of cells, N 5 3, P , 0.01).
TUNEL staining
The fragmented DNA of apoptotic cells was measured by
the catalytic incorporation of fluorescein-12-dUTP at the
39-OH ends using the enzyme terminal deoxynucleotidyl
transferase. TUNEL positive cells were not present in the
control cells (Fig. 4A). However, in cells treated for 24
hours with 4.2 nM CsA, fluorescence (arrow) indicative of
the fluorescein-12 dUTP incorporation into apoptotic cells
was apparent (Fig. 4B).
Use of flow cytometric light scatter measurements to
discriminate between viable, apoptotic and necrotic cells
The comparative effects of high (42 mM) and low (4.2 nM)
doses of CsA on the light scattering properties of the
LLC-PK1 cells are shown in a representative experiment in
Figure 5. In the control cells (Fig. 5A), the majority of cells
(81%) were in one major population that was taken to
represent viable cells. Approximately 6% of control cells
appeared in a region of increased SSC and decreased FSC,
indicative of increased granularity and decreased cell vol-
ume, respectively, and which was termed the “apoptotic”
region. Treatment with 4.2 nM CsA (Fig. 5B) increased the
proportion of cells in this “apoptotic” population to 15%.
In contrast, treatment with the higher 42 mM dose (Fig. 5C)
caused an appearance of a third population (35% of total
population) with increased FSC and decreased SSC. This
population, which has an increased cell size and a de-
creased cell granularity, was described as “necrotic.”
FITC-annexin V binding
The externalization of phosphatidylserine was assessed
by measuring FITC-annexin V binding by flow cytometry
(Fig. 6). One representative experiment out of three is
shown. It can be seen that treatment with CsA (4.2 nM) for
Fig. 4. Apoptosis detection following cyclosporine (CsA) treatment using
the TUNEL assay. Cells were treated for 24 hours with 4.2 nM CsA and
apoptotic cells were detected using the TUNEL assay. Arrows indicate
TUNEL positive cells. (A) Cells treated with vehicle alone. (B) Cells
treated for 24 hours with 4.2 nM CsA.
Table 2. Time-dependent induction of apoptosis by cyclosporine (CsA
4.2 nM) in LLC-PK1 cells
Time hr % Apoptosis
0 3 6 1
2 4 6 1
4 3 6 1
6 5 6 1
8 5 6 1
12 6 6 1
24 14 6 3a
LLC-PK1 cells were treated for 2 to 24 hr with 4.2 nM CsA. The
percentage of apoptotic cells was determined by PI staining and was
quantified as the percentage of cells displaying reduced DNA stainability
in the sub G0/G1 peak. Results are expressed as the mean 6 SEM of 3
independent experiments.
a P , 0.01
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24 hours induced an increase in the percentage of cells
displaying annexin-V binding from 6% in control cells to
12% in treated cells. These cells displayed an intact plasma
membrane as indicated by trypan blue exclusion.
Alterations in Fas expression
Alterations in Fas expression following CsA treatment
are shown in Figure 7. Low dose CsA (4.2 nM) treatment
for 24 hours was seen to cause a significant elevation in the
expression of Fas in LLC-PK1 cells (Fig. 7A, N 5 3, P ,
0.05), as evidenced by flow cytometric immunofluoresence
techniques (Fig. 7B). This was supported by Western blot
analysis where an increase in the expression of the 45 kD
Fas protein was seen (Fig. 7C). In both cases, the appro-
priate isotype controls were included (results not shown).
Fig. 5. Flow cytometric assessment of the effects of a low and high dose
of cyclosporine (CsA) on the size and granularity of LLC-PK1 cells.
Forward light scatter (FSC) and side light scatter (SSC) of the laser beam
were used as indices of size and granularity, respectively. Results from one
representative experiment which represent 10,000 events (cells) are
shown. (A) Control. (B) 4.2 nM CsA. (C) 42 mM CsA.
Fig. 6. FITC-annexin V binding in LLC-PK1 cells following cyclosporine
(CsA) exposure. Cells were treated for 24 hr with 4.2 nM CsA. The
externalization of phosphatidylserine was assessed by measuring FITC-
annexin V binding. The far right peak represents cells which have bound
FITC-annexin V. One representative experiment out of 3 is shown.
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Effects of the Fas antibody in the presence and absence
of CsA on the light scattering properties of LLC-PK1
cells
The light scattering properties of cells incubated in the
absence of primary anti-Fas antibody are shown in Figure
8A. Examination of the light scattering properties of both
non-CsA treated (Fig. 8B) and CsA treated cells (Fig. 8C)
that were both incubated with the Fas antibody demon-
strated increases in the proportions of “apoptotic” cells in
both cases in up to 32% and 70% of the total population,
respectively. Therefore, this “apoptotic” population was
much more evident in the CsA treated cells (Fig. 8C).
DISCUSSION
In this study, we have demonstrated that CsA has direct
toxic effects on the renal proximal tubular LLC-PK1 epi-
thelial cell line. All doses of CsA used caused a blockade in
the G0/G1 phase of the cell cycle. Low dose (4.2 nM) CsA
induced apoptosis whereas high dose (21 mM or greater)
CsA induced necrosis. Other investigators have reported
that severe injury to tissues usually results in necrosis, but
mild injury is capable of stimulating apoptosis [16, 17, 22].
The CsA concentrations (0.42 nM to 83 mM) chosen in
this study were taken to reasonably approximate the con-
centration range reached in vivo in kidney tissue so as to
Fig. 7. Effect of cyclosporine (4.2 nM CsA) on the expression of Fas in LLC-PK1 cells. Cells were treated for 24 hours with 4.2 nM CsA, and Fas
expression was assessed using flow cytometric immunofluoresence and Western blotting technqiues as described in the Methods section. (A) Graphical
representation of Fas expression as assessed by flow cytometric immunofluoresence. Results are expressed as the percentage of control cell Fas
expression and represent the mean 6 SEM of 3 independent experiments. *P , 0.05. (B) Flow cytometric histogram illustrating the increase in Fas
expression following CsA treatment. (C) Western blot analysis of Fas expression.
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obtain a nephrotoxic profile in vitro that was relevant to the
clinical situation [23, 24]. We have previously shown that
short term exposure to low doses of CsA (less than 0.42
mM), while not causing any significant changes in cellular
viability, were capable of inducing sustained elevations in
intracellular calcium in LLC-PK1 cells [5, 6]. Several lines
of evidence suggest that in some cell types, alterations in
cytosolic calcium concentrations can regulate apoptosis by
stimulating endonuclease activity [25].
In the present study, it is evident that all doses of CsA
caused very significant decreases in DNA synthesis, as
indicated by reductions in 3H-thymidine incorporation.
This was supported by flow cytometric cell cycle analysis
where dose dependent elevations in the proportions of cells
in the G0/G1 phases of the cell cycle with concomitant
decreases of those in the S and G2/M phases were observed.
Protein synthesis was also decreased, but was only observed
using higher doses (21 mM or greater) of CsA. A CsA
induced blockade in the G0/G1 phase of the cell cycle has
been previously observed in a murine B cell line [26]. These
reports and the present findings indicate that DNA is a vital
target for CsA injury. The p53 tumor suppressor gene
encodes a transcriptional activator whose targets may in-
clude genes that regulate genomic stability, cellular re-
sponses to DNA damage and cell cycle progression [27, 28].
It has been postulated that in some cell types following
DNA damage, the gene product p53 is activated, which
causes cells to stall in the G0/G1 phase to allow vital repairs
to be carried out. If these repairs are not possible then cell
death by apoptosis is triggered [29–31]. This indeed may be
the case for the lower doses (in the nM range) of CsA, which
in addition to causing the cell cycle blockade, induces
changes in the cells indicative of apoptotic cell death.
In this study, flow cytometry was seen to be a useful tool
for the discrimination between apoptotic and necrotic cell
death induced following a toxic insult. Necrosis and apo-
ptosis are two distinct modes of cell death that differ both
in morphology and in mechanism [7, 8]. Apoptosis is
characterized by cell shrinkage, chromatin condensation,
compaction of organelles, systematic DNA cleavage and is
genetically regulated. In contrast, in necrotic cell death the
plasma membrane is the major site of damage leading to
cell swelling and ultimate rupture of cells. Alterations in
the light scattering properties of cells can be used to
distinguish between apoptotic, necrotic and viable cells
[32]. In this study, cells treated with high doses of CsA (mM
range) displayed increases in forward light scatter (FSC)
indicative of cell swelling that was paralleled by a decreased
side light scatter (SSC), which indicates a decreased gran-
ularity probably due to rupturing of the cell and increased
release of cellular organelles. Cells treated with these high
doses also displayed alterations in membrane integrity as
evidenced by a decreased ability to exclude trypan blue and
release of LDH. However, cells treated with lower doses of
CsA showed decreases in FSC and increases in SSC
indicative of cell shrinkage and an increase in granularity,
respectively. This was paralleled by the appearance of a
“sub-G0/G1” peak on the DNA histogram that is taken to
represent decreased DNA stainability due to DNA degra-
dation probably mediated by endonuclease activity [33, 34].
This peak did not appear with cells treated with higher
doses of CsA. Cells treated for longer time points of 48
hours demonstrated a further increase in the size of this
“sub-G0/G1” peak (results not shown). Using the TUNEL
assay [20] further evidence for the induction of DNA
fragmentation and apoptosis by 4.2 nM CsA in LLC-PK1
cells was provided.
When cell death occurs, phosphatidylserine is translo-
cated to the external surface of the membrane. This occurs
during the early stages of apoptosis when the cell mem-
brane remains intact. In this study, phosphatidylserine
externalization was assessed by measuring the extent of
FITC-annexin-V binding. Annexin-V is a Ca21 dependent
binding protein that has a high affinity for phosphatidylser-
ine [21]. Low dose CsA (4.2 nM) increased the level of
annexin-V binding while not causing any alterations in
membrane integrity, as assessed using trypan blue exclu-
sion. Therefore, it can be seen from these results that flow
cytometry including DNA analysis, cell size and granularity
and annexin-IV detection, is a useful technique that can be
used to distinguish both apoptotic and necrotic cells in
heterogeneous populations. This would not be possible
using, for example, DNA gel electrophoresis to assess cell
death. In fact, other studies have shown that changes
typical of apoptosis could be visualized earlier when drug
treated cells were studied by DNA flow cytometry com-
pared to those detected by DNA electrophoresis [35].
Apoptosis is a genetically regulated form of cell death. A
number of gene products have been implicated in its
regulation. These include c-fos, c-myc, p53, Bcl-2 and Fas
[36]. Most of these are known mainly for their roles in
proliferation control, and their involvement in apoptosis
provides further evidence for the important link between
cell cycle progression and apoptosis. The 45 kD cell surface
receptor Fas (APO-1/CD95) and its ligand are important
mediators of apoptosis and show several structural and
functional similarities to the TNF receptor system [37]. Fas
sensitive cells can be induced to undergo apoptosis either
via activation of the Fas receptor by its natural ligand or
with agonistic anti-Fas antibodies. The ability of Fas to
induce death is dependent on the balance between the
expression of death factors such as interleukin-1-converting
enzyme (ICE) and Fas-associated death domain (FADD)
and the expression of protective factors such as Bcl-2,
Bcl-xL, Bag-1 and Fas associated phosphatase (FAP-1)
[38]. In the present study, anti-Fas antibodies were used to
examine the role of Fas in CsA-induced apoptotic cell
death in LLC-PK1 cells. The reactivity of the Fas antibody
with porcine cells was confirmed by virtue of the fact that a
band corresponding to the exact molecular weight of Fas
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was apparent in the LLC-PK1 cellular extracts. Using flow
cytometry and Western blot analysis, a low dose of CsA (4.2
nM) was seen to cause elevations in Fas expression. This
alteration in Fas expression was paralleled by changes in
the light scattering properties of the cells that displayed
characteristics of apoptosis. In addition, the Fas antibody
itself appeared to increase the proportion of cells with
apoptotic light scattering characteristics, an observation
that has previously been reported in breast epithelial cells
[39]. The anti-Fas antibody alone also increased phospha-
tidylserine expression and induced alterations in morphol-
ogy typical of apoptosis (results not shown). It has been
speculated that agonistic antibodies may mimic the effect
of the ligand for the Fas receptor and therefore induce
apoptosis. Anti-Fas antibodies have been shown to induce
apoptosis in the glomerular region of the nephron, both in
vivo and in vitro [15, 40]. In addition murine proximal
tubular epithelial cells expressed a Fas transcript in culture
that could be up-regulated by lipopolysacchride (LPS) and
pro-inflammatory cytokines [41]. The Fas system has also
been implicated in a mouse model of ischemia-reperfusion
induced apoptosis in tubular epithelial cells [42]. Hence,
activation of the Fas receptor system could be an important
mechanism in the mediation of CsA-induced apoptotic
renal tubular epithelial cell death.
A recent study by Thomas and co-workers demonstrated
that CsA induced nephropathy in a rat model was associ-
ated with a marked increase in apoptosis of tubular and
interstitial cells [43]. Furthermore, the CsA-induced apo-
ptosis correlated with interstitial fibrosis. In that in vivo
study, evidence was presented that the CsA-induced apo-
ptosis of tubular and interstitial cells was partially mediated
by angiotensin II and nitric oxide inhibition, suggesting a
role for renal ischemia in the process [43]. However, our
present study now also provides evidence for a direct effect
of CsA in inducing apoptosis in renal tubular cells.
In addition to our findings on a possible involvement of
the Fas system in CsA mediated apoptosis, the fact that
CsA was seen to induce sustained elevations in cytosolic
calcium in our cellular system [5, 6] also suggests that
calcium may be involved in activating calcium dependent
endonucleases, which in turn mediate DNA fragmentation
that gave rise to the “sub-G0/G1 peak” observed on the flow
cytometric DNA histogram. The calcium and magnesium
dependent nuclease involved in mediating glucocorticoid
induced apoptosis in rat thymocytes NUC18 [44] has been
shown to have sequence homology to the CsA binding
proteins cyclophilins A, B and C. In addition, the recom-
binant cyclophilins A, B and C have been shown themselves
to have an inherent nuclease activity [45, 46]. We have
localized cyclophilin A within LLC-PK1 cells [6] and cyclo-
philin C has been found to be present in high amounts in
the proximal tubule [47, 48]. Therefore, it is also conceiv-
able that CsA may mediate DNA damage within the kidney
Fig. 8. Effect of the Fas antibody in the presence and absence of
cyclosporine (CsA) on the light scattering properties of LLC-PK1 cells.
(A) Light scattering properties of control cells incubated in the absence of
primary antibody (2/1). (B) Light scattering properties of control cells
incubated with both primary and secondary antibody (1/1). (C) Light
scattering properties of CsA treated cells incubated with both primary and
secondary antibody.
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via its cytosolic binding proteins the cyclophilins, which
have inherent endonuclease activity.
In summary, the results from this study indicate that all
doses of CsA induce a block in the G0/G1 phase of the cell
cycle of LLC-PK1 cells, a renal epithelial cell line of
proximal tubular origin. The mechanism of cell death
induced by CsA in these proximal tubular cells is dose
dependent and Fas may be an important mediator of the
CsA induced apoptosis.
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